Biogen Inc (NASDAQ:BIIB) over-valued by 14%
Website | https://www.biogen.com/ |
Sector | Healthcare |
Industry | Drug Manufacturers General |
Fiscal Year End | Dec 31, 2020 |
Market Cap | $40,851,947,520 |
Beta | 0.56693 |
Average Volume | $1,281,540 |
Last Dividend | 0% |
Price on Feb 3, 2021 | $268.17 |
Autochartist™ Valuation | $231.07 |
Conclusion |
14% over-valued |
Download Report |